Resistance mutations, drug binding and drug residence times

Area of Science:

• Biochemistry
• Pharmacology
• Computational Biology

Background:

• Microbial and cancer cell evolution leads to drug resistance, complicating treatment of infectious diseases and tumors.
• Understanding protein-drug complex structures aids in designing better drugs and elucidating resistance mechanisms.
• Drug resistance is a significant hurdle in treating various diseases, necessitating novel therapeutic strategies.

Purpose of the Study:

• To explore the challenges in predicting mutation-driven drug resistance.
• To highlight the importance of protein and drug dynamics in understanding drug efficacy.
• To discuss strategies for increasing drug residence time and reducing resistance.

Main Methods:

• Review of computational methods for assessing mutation effects on drug binding and residence.
• Analysis of knowledge derived from protein-drug complexes for resistance mitigation.
• Exploration of strategies to enhance drug efficacy through increased residence time.

Main Results:

• Drug resistance is a common phenomenon due to rapid evolution of pathogens and cancer cells.
• Protein-drug complex structures offer insights but predicting mutation effects remains challenging.
• Computational approaches are being developed to model mutation impacts on drug binding and residence.

Conclusions:

• Considering protein and drug dynamics is crucial for understanding drug resistance.
• Developing accurate computational methods for predicting mutation effects is an ongoing challenge.
• Knowledge of protein-drug interactions informs the design of strategies to combat mutation-driven drug resistance.